These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28825467)

  • 21. Crystal structures of the ligand-binding domain of human peroxisome proliferator-activated receptor δ in complexes with phenylpropanoic acid derivatives and a pyridine carboxylic acid derivative.
    Oyama T; Takiguchi K; Miyachi H
    Acta Crystallogr F Struct Biol Commun; 2022 Feb; 78(Pt 2):81-87. PubMed ID: 35102897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alshammari MA; Attia SM
    Neurochem Int; 2018 Nov; 120():251-261. PubMed ID: 30227151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.
    Vittoria Simonini M; Polak PE; Boullerne AI; Peters JM; Richardson JC; Feinstein DL
    ASN Neuro; 2010 Jan; 2(1):e00025. PubMed ID: 20001953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.
    Chen ZC; Lee KS; Chen LJ; Wang LY; Niu HS; Cheng JT
    PLoS One; 2013; 8(5):e64229. PubMed ID: 23724037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of an orally available "Y"-shaped biaryl peroxisome proliferator-activated receptor δ agonist.
    Kim DS; Lee J; Londhe AM; Kadayat TM; Joo J; Hwang H; Kim KH; Pae AN; Chin J; Cho SJ; Kang H
    Bioorg Med Chem; 2018 Aug; 26(15):4382-4389. PubMed ID: 30054191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity].
    Kasuga J; Oyama T; Nakagome I; Aoyama A; Sako K; Makishima M; Hirono S; Morikawa K; Hashimoto Y; Miyachi H
    Yakugaku Zasshi; 2009 Jun; 129(6):709-18. PubMed ID: 19483413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice.
    Matsushita Y; Ogawa D; Wada J; Yamamoto N; Shikata K; Sato C; Tachibana H; Toyota N; Makino H
    Diabetes; 2011 Mar; 60(3):960-8. PubMed ID: 21270242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
    Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
    ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat.
    Kapoor A; Collino M; Castiglia S; Fantozzi R; Thiemermann C
    Shock; 2010 Aug; 34(2):117-24. PubMed ID: 19997057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
    An YQ; Zhang CT; Du Y; Zhang M; Tang SS; Hu M; Long Y; Sun HB; Hong H
    Metab Brain Dis; 2016 Jun; 31(3):663-71. PubMed ID: 26864581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances and Challenges in Drug Design of PPARδ Ligands.
    Maltarollo VG; Kronenberger T; Windshugel B; Wrenger C; Trossini GHG; Honorio KM
    Curr Drug Targets; 2018; 19(2):144-154. PubMed ID: 28413978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
    Okazaki S; Shioi R; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
    Bioorg Med Chem; 2016 Nov; 24(21):5455-5461. PubMed ID: 27622746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
    Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ
    Reddy AT; Lakshmi SP; Banno A; Reddy RC
    ACS Chem Biol; 2018 Dec; 13(12):3269-3278. PubMed ID: 30398845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.
    Briand F; Naik SU; Fuki I; Millar JS; Macphee C; Walker M; Billheimer J; Rothblat G; Rader DJ
    Clin Transl Sci; 2009 Apr; 2(2):127-33. PubMed ID: 20169010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro.
    Kuo SC; Ku PM; Chen LJ; Niu HS; Cheng JT
    Horm Metab Res; 2013 Nov; 45(12):880-6. PubMed ID: 23803968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
    Paterniti I; Mazzon E; Riccardi L; Galuppo M; Impellizzeri D; Esposito E; Bramanti P; Cappellani A; Cuzzocrea S
    Surgery; 2012 Jul; 152(1):90-106. PubMed ID: 22521259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.
    Filzen GF; Bratton L; Cheng XM; Erasga N; Geyer A; Lee C; Lu G; Pulaski J; Sorenson RJ; Unangst PC; Trivedi BK; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3630-5. PubMed ID: 17512197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.